The Drugs (Prices Control) Order, 2013 | Bare Act | Universal Lexis Nexis | Commentaries on Trade & Regulatory Laws | 2025 Edition

"The Drugs (Prices Control) Order, 2013", a comprehensive and indispensable resource for anyone seeking a thorough understanding of drug pricing regulations. Published by Universal Lexis Nexis, this 2023 edition is the latest and most up-to-date version of this important legal reference.

In a single paragraph, this bare act provides a concise overview of the Drugs (Prices Control) Order, 2013, allowing readers to quickly grasp the key principles and provisions governing drug pricing. It covers a wide range of topics, including the regulation of pharmaceutical prices, control over the manufacture and sale of drugs, and the establishment of pricing mechanisms and committees. This edition incorporates relevant amendments and updates to ensure the information is accurate and current.

?? This bare act is a must-have for legal professionals, pharmaceutical companies, researchers, and policymakers involved in the healthcare industry. It provides a comprehensive and reliable reference point for navigating the complex landscape of drug pricing regulations.

?? With its user-friendly layout and easy-to-understand language, this 2023 edition of "The Drugs (Prices Control) Order, 2013" ensures accessibility for both experts and newcomers to the field. It is an essential tool for legal research, policy advocacy, and compliance management.

Title:	The Drugs (Prices Control) Order, 2013 | Bare Act | Universal Lexis Nexis | Commentaries on Trade & Regulatory Laws | 2025 Edition
Edition	2025
Author:	universal lexis nexis
Publisher	universal lexis nexis